Skip to content

Choosing a Stability Storage CDMO: 5 Questions to Ask

If you’ve ever chased a pull point, scrambled for overflow space, or worried about a chain‑of‑custody gap, you know choosing the right stability storage CDMO to partner with isn’t optional, it’s critical. Outsourcing stability storage is becoming the norm as product portfolios expand, pipelines accelerate, and internal facilities face mounting pressure. Stability studies touch every regulatory submission and every quality system, which means the decisions you make early on can strengthen your compliance position or expose your programme to avoidable risk.

When timelines are tight and internal capacity is stretched, partnering with a specialist for GMP stability storage is often the safest, fastest way to keep studies on track. The right choice reduces risk; the wrong one can create audit gaps, missed pulls, or capacity bottlenecks.

Audit red flags to avoid

  • Unclear pull scheduling and ownership
  • Missed pull points for testing
  • Temperature excursion handling without documentation
  • Weak chain‑of‑custody between your site and the CDMO
  • Insufficient surge/overflow planning
  • Ambiguous responsibilities in the Quality Agreement

5 questions to ask before you outsource stability storage

Here are five practical questions our Quality team recommends you ask any prospective stability storage CDMO, and why the answers protect your timelines, data integrity, and submissions.

1. What volume and conditions will you manage for us, and how will reliability be built in?

Every stability programme is different. Some require small exploratory batches; others involve thousands of samples across multiple ICH and custom conditions. The right CDMO should demonstrate flexibility, capacity, and built‑in reliability.

When evaluating a stability storage CDMO, reliability should be your non‑negotiable. A storage partner should comfortably handle anything from a handful of samples to a full commercial batch, across multiple conditions.

Ask for proof of:

  • A breadth of conditions: ICH, custom, photostability, thermal cycling
  • Digital oversight: Inventory management systems with real‑time chamber performance alerts.
  • Traceability: Robust barcode/label controls and verifiable chain‑of‑custody data.
  • Redundancy: Backup power, backup chambers, and documented disaster‑recovery plans.
  • Sample pull assurance: Systems designed to prevent human‑driven scheduling errors and prevent missed sample pulls.

Why it matters: These controls protect your batches from interruptions, keep pulls on schedule, and keep your data submission‑ready.

Not sure how much capacity to request? Ask us to model your expected sample volumes and conditions versus available storage capacity.

2. Are there special handling or regulatory requirements we need to plan for?

Many studies involve materials with elevated handling or compliance requirements e.g. controlled substances, potent compounds, hazardous materials, or biologics with complex temperature profiles. Raising these requirements up front ensures the right SOPs, restricted access, training, and logistics are in place before your first delivery.

Ask:

  • Do you have SOPs for controlled drug storage and restricted access areas?
  • Can you support hazardous classifications or biosafety‑related requirements?
  • How are deviations, OOS, and excursions documented and escalated?
  • How do your SOPs align with our Quality Agreement?

Why it matters: Regulatory oversight applies to both you and your CDMO. Early clarity avoids rework, delays, deviations, or misalignment between your quality system and theirs.

Share your requirements and we’ll flag any gaps or misalignments before execution.

3. How do you manage overflow, surge periods, or emergency backup needs?

Storage demand rarely stays flat. Seasonal spikes, new studies, or unexpected internal constraints can all require rapid scale‑up. A resilient CDMO will model capacity, reserve contingency space, and prioritise continuity so your studies never queue or stall.

This forward‑looking approach helps protect study timelines and reduces the risk of last‑minute scrambling.

Look for:

  • Forward capacity planning tied to your pipeline
  • Reserved surge/disaster‑recovery space
  • Clear SLAs for intake during peak demand
  • Escalation paths when multiple studies compete for the same conditions

Why it matters: You get confidence that timelines won’t slip during growth spurts or equipment outages.

If you’re facing a surge, ask about our contingency space and how we protect studies during peak periods.

4. Can we share our study game plan, and how will you translate it into an operational schedule?

A clear plan makes everything easier for both you and your storage partner.

Key details to share upfront include:

  • Total sample counts
  • Storage conditions
  • Number of batches
  • Pull points and timelines

A specialist stability storage CDMO will convert your protocol into an execution‑ready schedule with:

  • A detailed pull calendar
  • Labelling and barcoding structure
  • Full chain‑of‑custody documentation

Where Q1 Scientific adds value: Stability Strategy Sessions

We take planning a step further with our Lunch & Learn Stability Strategy Sessions. These collaborative workshops are designed to help teams refine their study plans before they reach an operational stage. These sessions help surface hidden pinch points, clarify pull assumptions, and build contingency where needed, so your plan is operationally realistic.

What you’ll get from a Strategy Session:

  • Pull plan clarity: Validate intervals, batch staggering, and sample counts
  • Operational fit: Translate protocol requirements into a workflow
  • Risk radar: Identify logistics, compliance, and capacity risks early

Book a Strategy Session to map your protocol, operational schedule and de‑risk pulls from day one.

Why this matters: By aligning early, whether through shared documentation or a structured strategy session, both sides work from the same roadmap. The result is smoother execution, fewer errors, faster responses, and stronger data integrity. Even if you are still finalizing the details, experienced partners can help shape pull schedules, flag risks, and build flexibility into the plan from day one.

5. How are samples transported, and what controls protect them in transit?

Transport is often the weakest link in chain‑of‑custody. Temperature excursions, unclear handovers, and documentation gaps often originate during movement from site to storage.

Expect your stability storage CDMO to provide:

  • Validated, temperature‑controlled shipping processes
  • Real‑time monitoring during transit
  • Documented handovers
  • Contingency planning for delays or excursions

Why it matters: A strong logistics chain prevents invisible risks from creeping in before your samples even reach the chamber.

Ask us about our sample transportation service.

Practical next steps with your storage CDMO

  1. Define user requirements (scope, standards, budget, timing, growth).
  2. Shortlist and meet operations leadership (not just sales) to validate capacity fit.
  3. Audit early; finalize the Quality Agreement with clear roles and communication protocols.
  4. Schedule regular check‑ins across QA, operations, and project leads.

Why teams choose Q1 Scientific for stability storage

  • Regulatory alignment: Built for GMP expectations with qualified chambers, and audit‑ready documentation, so your stability data is always regulatory compliant.
  • Global capacity: Multi‑site storage in Ireland, Belgium, and the US gives you scalable capacity, transparent scheduling, and built‑in contingency space.
  • End‑to‑end continuity: Stability storage is our core focus. Every intake, label, pull, and handover follows harmonised SOPs backed by digital traceability. Validated logistics, real-time monitoring, digital traceability, and audit‑ready documentation at every step ensure no weak links between your site and ours.
  • A partner you can trust: Zero missed pulls and a proven track record supporting clinical and commercial programmes. Our customers recognise this and in 2025, we achieved an industry‑leading Net Promoter Score of 71, reflecting strong trust, repeat business, and high satisfaction across pharma, biotech, and medtech companies.

Ready to de‑risk your stability storage programme?

Talk to our team about capacity, conditions, and timelines, or send your protocol and we’ll help you map your pull schedule and contingencies.

Choose the next step that fits with where you are today:

 

 

 

 

Attribution

Portions of the perspectives in this article were shared in a StabilityHub feature on stability CDMOs and a related webinar panel that included Q1 Scientific’s Quality Manager, Aideen Glynn.

FAQs: Choosing a Stability Storage CDMO

1) What is a “stability storage CDMO”?

A CDMO that specialises in GMP stability storage, housing your samples under controlled conditions (ICH and custom), managing pull schedules, labelling/barcoding, chain‑of‑custody, and logistics documentation to support regulatory submissions.

2) What should a Quality Agreement include for stability storage?

Scope and responsibilities, deviation/excursion handling, change control, data and documentation ownership, communication/escalation pathways, audit rights, and KPIs for service performance (e.g., pull timeliness, temperature alarm response).

3) How do you ensure chain‑of‑custody and traceability?

Through barcoded intake/label controls with our custom-built Electronic Sample Tracking System (ESTS), documented handovers, temperature‑controlled logistics with monitoring, and an auditable trail from sample receipt to pull and return or destruction.

4) What’s the difference between ICH and custom conditions?

ICH conditions follow internationally harmonised guidelines for temperature and humidity setpoints; custom conditions are tailored to product‑specific needs (e.g., stress conditions, R&D purposes). Your CDMO should support both and document all setpoints and tolerances.

5) Can you support controlled substances or hazardous materials?

Yes, Q1 Scientific has the appropriate SOPs, restricted access, training, and regulatory permissions. Raise these requirements at the outset to ensure compliant handling and avoid delays.

6) What happens if my onsite chamber fails or we need to scale suddenly?

Q1 Scientific maintains redundancy (backup chambers/power) and reserves contingency space so studies continue uninterrupted during maintenance, outages, or surge periods.

7) How do Lunch & Learn Stability Strategy Sessions work?

They’re short, collaborative workshops to pressure‑test your protocol before execution. You’ll clarify pull schedules, sample counts, and logistics, and identify risks and contingencies early. It’s no obligation, practical guidance tailored to your study.

8) How quickly can we onboard a new study and get samples into storage?

Most studies can be onboarded rapidly once we receive your protocol, sample counts, and required conditions. Early engagement, especially through a Stability Strategy Session, helps streamline onboarding and ensures your pull calendar is execution‑ready from day one.